Target Price | HKD37.71 |
Price | HKD33.80 |
Potential |
11.56%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target JD Health International 2026 .
The average JD Health International target price is HKD37.71.
This is
11.56%
register free of charge
HKD46.35
37.12%
register free of charge
HKD23.28
31.13%
register free of charge
|
|
A rating was issued by 13 analysts: 10 Analysts recommend JD Health International to buy, 2 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the JD Health International stock has an average upside potential 2026 of
11.56%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion HKD | 59.15 | 61.84 |
8.84% | 4.55% | |
EBITDA Margin | 1.60% | 3.10% |
16,955.58% | 93.34% | |
Net Margin | 4.10% | 5.66% |
398.79% | 38.12% |
11 Analysts have issued a sales forecast JD Health International 2024 . The average JD Health International sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an JD Health International EBITDA forecast 2024. The average JD Health International EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 JD Health International Analysts have issued a net profit forecast 2024. The average JD Health International net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share HKD | 0.76 | 1.10 |
442.86% | 44.74% | |
P/E | 32.27 | |
EV/Sales | 1.00 |
3 Analysts have issued a JD Health International forecast for earnings per share. The average JD Health International <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the JD Health International stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
JD Health International...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.